Michael Carroll
Stock Analyst at RBC Capital
(3.73)
# 3,077
Out of 4,827 analysts
210
Total ratings
55.81%
Success rate
3.54%
Average return
Main Sectors:
Stocks Rated by Michael Carroll
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VRDN Viridian Therapeutics | Maintains: Outperform | $46 → $45 | $12.84 | +250.47% | 1 | May 7, 2025 | |
VTR Ventas | Maintains: Outperform | $74 → $75 | $65.58 | +14.36% | 20 | May 7, 2025 | |
PLD Prologis | Maintains: Sector Perform | $128 → $117 | $105.49 | +10.91% | 13 | Apr 29, 2025 | |
FR First Industrial Realty Trust | Maintains: Outperform | $62 → $58 | $49.41 | +17.39% | 11 | Apr 29, 2025 | |
EGP EastGroup Properties | Maintains: Sector Perform | $189 → $183 | $167.01 | +9.57% | 12 | Apr 29, 2025 | |
AHR American Healthcare REIT | Reiterates: Outperform | $34 | $32.21 | +5.56% | 3 | Mar 19, 2025 | |
MPW Medical Properties Trust | Maintains: Sector Perform | $4 → $5 | $5.19 | -3.66% | 10 | Mar 10, 2025 | |
KRC Kilroy Realty | Maintains: Sector Perform | $44 → $39 | $31.13 | +25.28% | 7 | Mar 10, 2025 | |
DEA Easterly Government Properties | Maintains: Underperform | $30 → $28 | $20.26 | +35.74% | 8 | Mar 10, 2025 | |
LINE Lineage | Maintains: Outperform | $81 → $74 | $44.71 | +65.51% | 4 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $58 | $51.67 | +12.25% | 11 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $37 → $32 | $28.95 | +10.54% | 13 | Feb 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $40 → $38 | $33.86 | +12.23% | 9 | Jan 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $125 → $114 | $73.69 | +54.70% | 16 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $17.34 | +73.01% | 14 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $39 → $43 | $35.55 | +20.96% | 2 | Nov 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $26 | $17.39 | +49.51% | 10 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $2 → $3 | $2.96 | +1.35% | 1 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $101 → $114 | $148.25 | -23.10% | 11 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $32 | $35.82 | -10.66% | 12 | Mar 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $185 | $204.45 | -9.51% | 3 | Feb 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $10 → $7 | $4.80 | +45.83% | 7 | May 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $14 | $0.27 | +5,083.27% | 4 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $20 → $12 | $3.09 | +288.35% | 6 | Jul 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $17 → $19 | $13.46 | +41.16% | 2 | Sep 1, 2021 |
Viridian Therapeutics
May 7, 2025
Maintains: Outperform
Price Target: $46 → $45
Current: $12.84
Upside: +250.47%
Ventas
May 7, 2025
Maintains: Outperform
Price Target: $74 → $75
Current: $65.58
Upside: +14.36%
Prologis
Apr 29, 2025
Maintains: Sector Perform
Price Target: $128 → $117
Current: $105.49
Upside: +10.91%
First Industrial Realty Trust
Apr 29, 2025
Maintains: Outperform
Price Target: $62 → $58
Current: $49.41
Upside: +17.39%
EastGroup Properties
Apr 29, 2025
Maintains: Sector Perform
Price Target: $189 → $183
Current: $167.01
Upside: +9.57%
American Healthcare REIT
Mar 19, 2025
Reiterates: Outperform
Price Target: $34
Current: $32.21
Upside: +5.56%
Medical Properties Trust
Mar 10, 2025
Maintains: Sector Perform
Price Target: $4 → $5
Current: $5.19
Upside: -3.66%
Kilroy Realty
Mar 10, 2025
Maintains: Sector Perform
Price Target: $44 → $39
Current: $31.13
Upside: +25.28%
Easterly Government Properties
Mar 10, 2025
Maintains: Underperform
Price Target: $30 → $28
Current: $20.26
Upside: +35.74%
Lineage
Mar 6, 2025
Maintains: Outperform
Price Target: $81 → $74
Current: $44.71
Upside: +65.51%
Mar 6, 2025
Maintains: Outperform
Price Target: $50 → $58
Current: $51.67
Upside: +12.25%
Feb 21, 2025
Maintains: Outperform
Price Target: $37 → $32
Current: $28.95
Upside: +10.54%
Jan 27, 2025
Maintains: Sector Perform
Price Target: $40 → $38
Current: $33.86
Upside: +12.23%
Dec 17, 2024
Maintains: Sector Perform
Price Target: $125 → $114
Current: $73.69
Upside: +54.70%
Nov 13, 2024
Maintains: Outperform
Price Target: $33 → $30
Current: $17.34
Upside: +73.01%
Nov 11, 2024
Maintains: Sector Perform
Price Target: $39 → $43
Current: $35.55
Upside: +20.96%
Nov 4, 2024
Maintains: Outperform
Price Target: $25 → $26
Current: $17.39
Upside: +49.51%
Oct 14, 2024
Maintains: Underperform
Price Target: $2 → $3
Current: $2.96
Upside: +1.35%
Aug 9, 2024
Maintains: Sector Perform
Price Target: $101 → $114
Current: $148.25
Upside: -23.10%
Mar 11, 2024
Reiterates: Sector Perform
Price Target: $32
Current: $35.82
Upside: -10.66%
Feb 2, 2024
Reiterates: Sector Perform
Price Target: $185
Current: $204.45
Upside: -9.51%
May 30, 2023
Maintains: Sector Perform
Price Target: $10 → $7
Current: $4.80
Upside: +45.83%
Mar 7, 2023
Downgrades: Underperform
Price Target: $14
Current: $0.27
Upside: +5,083.27%
Jul 25, 2022
Maintains: Sector Perform
Price Target: $20 → $12
Current: $3.09
Upside: +288.35%
Sep 1, 2021
Maintains: Sector Perform
Price Target: $17 → $19
Current: $13.46
Upside: +41.16%